Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the ...

Paris: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) ...

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by ...

Medical experts have raised concerns over the soaring costs and scarcity of diabetes medications in Nigeria. They also revealed that the number of individuals living with diabetes in the country has ...

No fewer than 10 companies have shut down or relocated their operations from Nigeria due to the current economic challenges, ...

Increasing global temperatures wrought by greenhouse gas emissions have boosted the number of dengue cases, new research ...

Health stocks tumbled as vaccine sceptic RFK Jr. was named by President-elect Trump to head the Department of Health and ...

Paris-listed Sanofi, a producer of flu vaccines, slid 4.4% to hit a four-month low. Overnight, Asian stocks were mostly ...

The banks have been quietly celebrating. The oil and gas giants are preparing fresh investment plans. The tech giants have ...

The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...

Last week saw US pharma major AbbVie release disappointing Phase II trial results on its emraclidine in schizophrenia, which ...